Madison’s local CBS affiliate, WISC-TV/Ch. 3, recently put the spotlight on a research project that’s being led by UW-Madison’s Lisa Cadmus-Bertram.
The 12-week randomized trial, WISC reports, will enroll 50 breast and colorectal cancer survivors. Half will make up a control group while the remaining will participate in an intervention group. Patients in the control group receive standard follow-up care and a survivorship plan.
WISC explains how patients in the intervention group will receive the same care as the control group, but also will receive a Fitbit and online coaching. The daily step count data from the Fitbit will be uploaded to the patients MyChart account and can be monitored by their physician.
Cadmus-Bertram is an assistant professor with the School of Education’s Department of Kinesiology
. She directs the Wisconsin Physical Activity Epidemiology Lab
and is a member of the Cancer Prevention and Control program at the UW Carbone Cancer Center, where the clinical trial is housed.
“We have good evidence to suggest that women who are more active are less likely to develop breast cancer and also some pretty good evidence now suggests that physical activity after a diagnosis can be protecting of negative outcomes after a cancer diagnosis,” Cadmus-Bertram tells WISC.
To learn more about this project, check out the news report from WISC-TV’s Dave Delozier on this channel3000.com web page.